Basilea Pharmaceutica(CH:BSLN)
CHF 71.60+0.60 (+0.85%)
CH:BSLN
Basilea Pharmaceutica earnings date
CHF 71.60
At close:+0.60 (+0.85%)
Want to see CH:BSLN full AI Analyst Report?
Basilea Pharmaceutica (BSLN) Q2 2019 Earnings Report
9 Followers
CH:BSLN Q2 2019 EPS Results
- Actual EPS
- -CHF 1.44
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -CHF 2.07
CH:BSLN Q2 2019 Revenue Results
- Actual Revenue
- CHF 63.19M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +5.52%
Earnings Announcement Details
- Quarter
- Q2 2019
- Date
- 08/20/2019
- Time
- Before Open
- Conference Call
- Tuesday, August 20, 2019
CH:BSLN Upcoming Earnings
Basilea Pharmaceutica's next earnings date is estimated for February 16, 2027, based on past reporting schedules.
Q2 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:BSLN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 16, 2027 | 2026 (Q4) | 4.21- | 1.99 | ― | ― |
| Aug 18, 2026 | 2026 (Q2) | 3.342.13 | 1.26 | 69.05% (+0.87) | |
| Feb 17, 2026 | 2025 (Q4) | 1.641.99 | 4.7 | -57.70% (-2.71) | |
| Aug 19, 2025 | 2025 (Q2) | 2.031.26 | 1.57 | -20.00% (-0.32) | |
| Feb 18, 2025 | 2024 (Q4) | 3.244.70 | -1.71 | 375.66% (+6.41) | |
| Aug 13, 2024 | 2024 (Q2) | 1.171.57 | 2.43 | -35.21% (-0.86) | |
| Feb 13, 2024 | 2023 (Q4) | -2.02-1.71 | 2.05 | -183.17% (-3.75) | |
| Aug 15, 2023 | 2023 (Q2) | 0.812.43 | -1.03 | 336.02% (+3.46) | |
| Feb 14, 2023 | 2022 (Q4) | -1.302.05 | 1.26 | 62.70% (+0.79) | |
| Aug 16, 2022 | 2022 (Q2) | -1.27-1.03 | -1.84 | 44.02% (+0.81) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
